BioM News
  • BioM News
  • BioM News
  • BioM News
  • BioM News

BioM News

Please enter a searchword.

05.01.2017

Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance

Founded in Freising (near Munich), co-located in Boston (USA), NASDAQ-listed Pieris joins forces in immuno-oncology drug development with Servier Pharma (France).

05.12.2016

Recent developments in personalized medicine

On November 29 and 30, 230 experts from all over Europe participated in the 6th Munich Biomarker Conference in Munich. The international conference on personalized medicine was organized by BioM, the network agency of Bavaria’s biotechnology industry. Interdisciplinary exchange and dialogue between researchers, physicians, and industry had been...

15.10.2016

Strong immuno start in Munich: iOmx hits the ground running

Immuno-oncology startup iOmx Therapeutics has raised 40 million Euro in its first round of financing.

29.09.2016

Medigene (Munich) launches a billion-dollar collaboration with bluebird bio

"We are delighted to collaborate with bluebird bio, a leader in the field of cell and gene therapy, including cancer immunotherapy," said Dolores J. Schendel.

10.09.2016

Rigontec: 15 million euros for a new immunotherapy RNA-technology

The Munich-based firm also starts to gain a foothold in the American market by setting up a new company in the US (Boston).

17.05.2016

Horst Domdey in Nature Outlook: Research Commercialization

Munich Biotech Cluster and lessons learned in 20 years of support for entrepreneurship in biopharma.

20.04.2016

The building BioSysM

Opening of BioSysM on Campus Martinsried-Großhadern

On April 19th, the Center for Molecular Biosystems (BioSysM) of the Ludwig-Maximilians-Universität (LMU) celebrated its official opening. The new building on the High Tech Campus Martinsried-Großhadern...